Recent Advances in Prostate Cancer Treatment and Drug Discovery

Novel drugs, drug sequences and combinations have improved the outcome of prostate cancer in recent years. The latest approvals include abiraterone acetate, enzalutamide and apalutamide which target androgen receptor (AR) signaling, radium-223 dichloride for reduction of bone metastases, sipuleucel-...

Descripción completa

Detalles Bibliográficos
Autores principales: Nevedomskaya, Ekaterina, Baumgart, Simon J., Haendler, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983695/
https://www.ncbi.nlm.nih.gov/pubmed/29734647
http://dx.doi.org/10.3390/ijms19051359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983695/
https://www.ncbi.nlm.nih.gov/pubmed/29734647
http://dx.doi.org/10.3390/ijms19051359

Ejemplares similares